Physician profile
Todd E Kinnebrew
NPI 1932150729
$1,746.53
in general payments reported to CMS, 2019-2025
10 companies · $259 in 2025
The $259 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $269 · 2020: $200 · 2021: $17.24 · 2022: $69.76 · 2024: $932 · 2025: $259.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $777 · Food and Beverage: $414.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $776.79 |
| Food and Beverage | $414.23 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $471.35 | 2024 | |
| United Orthopedics LLC | $460.20 | 2024 | |
| Encore Medical, Lp | $364.79 | 2019-2020 | |
| Miach Orthopaedics, INC. | $211.95 | 2025 | |
| Zimmer Biomet Holdings, INC. | $66.94 | 2019-2020 | |
| Depuy Synthes Sales INC. | $56.23 | 2020-2022 | |
| Smith+Nephew, INC. | $47.52 | 2025 | |
| Innovation Technologies INC | $36.61 | 2022 | |
| Heron Therapeutics, INC. | $17.24 | 2021 | |
| Pfizer INC. | $13.70 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Todd Kinnebrew listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.